Does TALAZOPARIB Cause Embolism? 15 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Embolism have been filed in association with TALAZOPARIB (Talzenna). This represents 1.0% of all adverse event reports for TALAZOPARIB.
15
Reports of Embolism with TALAZOPARIB
1.0%
of all TALAZOPARIB reports
5
Deaths
13
Hospitalizations
How Dangerous Is Embolism From TALAZOPARIB?
Of the 15 reports, 5 (33.3%) resulted in death, 13 (86.7%) required hospitalization, and 2 (13.3%) were considered life-threatening.
Is Embolism Listed in the Official Label?
Yes, Embolism is listed as a known adverse reaction in the official FDA drug label for TALAZOPARIB.
What Other Side Effects Does TALAZOPARIB Cause?
Anaemia (219)
Neoplasm progression (169)
Death (142)
Off label use (78)
Thrombocytopenia (78)
Fatigue (77)
Platelet count decreased (68)
Haemoglobin decreased (65)
Febrile neutropenia (60)
Pancytopenia (60)
What Other Drugs Cause Embolism?
BEVACIZUMAB (378)
PACLITAXEL (251)
LENALIDOMIDE (206)
DEXAMETHASONE (204)
RITUXIMAB (204)
CYCLOPHOSPHAMIDE (202)
DOXORUBICIN (198)
RIVAROXABAN (197)
CARBOPLATIN (187)
APIXABAN (181)
Which TALAZOPARIB Alternatives Have Lower Embolism Risk?
TALAZOPARIB vs TALC
TALAZOPARIB vs TALIGLUCERASE ALFA
TALAZOPARIB vs TALIMOGENE LAHERPAREPVEC
TALAZOPARIB vs TALQUETAMAB
TALAZOPARIB vs TALQUETAMAB-TGVS